Tg Therapeutics (TGTX) Non-cash Items (2018 - 2025)

Tg Therapeutics' Non-cash Items history runs 8 years deep, the most recent figure standing at $3.6 million for Q4 2025.

• In Q4 2025, Non-cash Items fell 96.56% year-over-year to $3.6 million; the TTM figure through Dec 2025 stood at $3.6 million (down 96.56% YoY), while the FY2025 annual figure was $3.6 million, down 96.56% from the prior year.
• Non-cash Items was $3.6 million for Q4 2025 at Tg Therapeutics, down from $103.7 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $102.5 billion in Q1 2021 to a low of $3.6 million in Q4 2025.
• Historically, Non-cash Items has averaged $17.1 billion across 5 years, with a median of $38.6 million in 2021.
• The sharpest annual moves came in 2021 and 2025: Non-cash Items surged 1020.12% in 2021, then slumped 96.56% in 2025.
• A 5-year view of Non-cash Items shows it stood at $29.5 million in 2021, then declined by 15.04% to $25.1 million in 2022, then soared by 89.94% to $47.6 million in 2023, then surged by 117.81% to $103.7 million in 2024, then plunged by 96.56% to $3.6 million in 2025.
• The last three Non-cash Items figures came in at $3.6 million (Q4 2025), $103.7 million (Q4 2024), and $47.6 million (Q4 2023), per Business Quant data.